OverviewSuggest Edit

The mission of every team member at Carmat is to contribute to the development of innovative artificial organs – the artificial heart today, tomorrow other vital organs – to treat millions of patients affected by advanced disease of these organs and to restore their normal life.

By sharing our expertise and through our daily actions, we seek to achieve results that will benefit first and foremost patients and physicians, but also healthcare systems, subcontractors, employees and shareholders.

TypePublic
Founded2008
HQVélizy-Villacoublay, FR
Websitecarmatsa.com

Latest Updates

Employees (est.) (Feb 2021)108
Job Openings5
Share Price (Apr 2021)€27
Cybersecurity ratingAMore

Carmat Office Locations

Carmat has an office in Vélizy-Villacoublay
Vélizy-Villacoublay, FR (HQ)
36 Avenue de l'Europe immeuble l
Show all (1)

Carmat Financials and Metrics

Carmat Revenue

Market capitalization (7-Apr-2021)

413.4m

Closing stock price (7-Apr-2021)

27.0
Carmat's current market capitalization is €413.4 m.
Show all financial metrics

Carmat Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Carmat Online and Social Media Presence

Embed Graph

Carmat Blogs

CARMAT announces the issuance of a second tranche of equity warrants within the framework of its contingent equity line with Kepler Cheuvreux

L’article CARMAT announces the issuance of a second tranche of equity warrants within the framework of its contingent equity line with Kepler Cheuvreux est apparu en premier sur Carmat.

CARMAT obtains a €1.4 million grant as part of the “Industrial recovery plan – Strategic sectors” call for projects

L’article CARMAT obtains a €1.4 million grant as part of the “Industrial recovery plan – Strategic sectors” call for projects est apparu en premier sur Carmat.

Availability of the 2020 Universal registration document

L’article Availability of the 2020 Universal registration document est apparu en premier sur Carmat.

CARMAT receives FDA approval to use the new version of its artificial heart in the US Early Feasibility Study (EFS)

L’article CARMAT receives FDA approval to use the new version of its artificial heart in the US Early Feasibility Study (EFS) est apparu en premier sur Carmat.

CARMAT reports its financial results for 2020, and confirms its 2021 prospects

L’article CARMAT reports its financial results for 2020, and confirms its 2021 prospects est apparu en premier sur Carmat.

CARMAT appoints Prof. Christian Latrémouille as Director of Surgical Affairs

L’article CARMAT appoints Prof. Christian Latrémouille as Director of Surgical Affairs est apparu en premier sur Carmat.
Show more

Carmat Frequently Asked Questions

  • When was Carmat founded?

    Carmat was founded in 2008.

  • How many employees does Carmat have?

    Carmat has 108 employees.

  • Who are Carmat competitors?

    Competitors of Carmat include BiVACOR, Biotronik and Air-Tite Products.

  • Where is Carmat headquarters?

    Carmat headquarters is located at 36 Avenue de l'Europe immeuble l, Vélizy-Villacoublay.

  • Where are Carmat offices?

    Carmat has an office in Vélizy-Villacoublay.

  • How many offices does Carmat have?

    Carmat has 1 office.